Read more about High-Grade Serous Carcinoma
Jul 27, 2021
High-Grade Serous Carcinoma
...some patients, especially those with BRCA mutations. In 2020, PARP inhibitors received FDA approval as first-line therapy for a subset of patients with advanced ovarian cancers, and has been shown to...